↓ Skip to main content

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

Overview of attention for article published in Alzheimer's Research & Therapy, January 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
172 Mendeley